儿童中间葡萄膜炎:治疗与观察的对比研究
该回顾性研究比较了2000至2024年间三级转诊中心84例儿童中间葡萄膜炎患者(158眼)中接受治疗与仅观察者的特征。观察组眼前房细胞、玻璃体细胞、玻璃体混浊及视盘水肿均更轻,荧光素血管造影总分更低;治疗组52%出现高眼压、18.9%出现青光眼,观察组无此并发症,且最终视力相似。结论提示部分轻度儿童中间葡萄膜炎可安全观察。
要点
- 观察组炎症体征及荧光素血管造影渗漏均显著轻于治疗组。
- 治疗组高眼压和青光眼发生率分别为52%和18.9%,观察组无此并发症。
- 两组最终视力相似,观察组无需手术的并发症。
核心结论
- 并非所有儿童中间葡萄膜炎患者都需要治疗,部分轻度病例可安全观察而不出现慢性炎症后遗症。
研究设计与样本
- 回顾性图表综述,纳入2000至2024年三级转诊中心诊断为中间葡萄膜炎的儿童患者84例共158眼。
主要发现
- 158眼中127眼(80.4%)接受治疗,31眼(19.6%)仅观察。
- 观察组眼前房细胞(P < 0.007)、玻璃体细胞(P = 0.0005)、玻璃体混浊(P = 0.003)及视盘水肿(P = 0.03)均较治疗组轻。
- 观察组荧光素血管造影总分显著低于治疗组(P < 0.0001),其中视盘渗漏(P = 0.006)和视网膜毛细血管渗漏(P < 0.0001)评分更低。
- 治疗组66眼(52%)出现高眼压,24眼(18.9%)出现青光眼,观察组均无。
- 两组最终视力相似(20/32 vs. 20/25,P = 0.13),观察组无眼需手术并发症。
临床怎么用
- 对炎症体征轻、荧光素血管造影渗漏少的儿童中间葡萄膜炎患者,可考虑安全观察以减少药物副作用和治疗负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the characteristics of pediatric patients with pars planitis (PP) who received treatment versus those who were observed without treatment. METHODS: Retrospective chart review of pediatric patients diagnosed with PP at a tertiary referral center from 2000 to 2024. RESULTS: Of 158 eyes from 84 patients with PP, 127 eyes (80.4%) received treatment and 31 eyes (19.6%) were observed. Eyes that were observed presented with less anterior chamber cell ( P < 0.007), vitreous cell ( P = 0.0005), vitreous haze ( P = 0.003), and optic nerve head edema ( P = 0.03). The untreated group had significantly lower total fluorescein angiography scores ( P < 0.0001) than the treated group and specifically scored lower in disc leakage ( P = 0.006) and retinal capillary leakage ( P < 0.0001). In the treated group, 66 eyes (52%) developed ocular hypertension and 24 (18.9%) developed glaucoma, whereas the untreated group had no cases of either. Final visual acuity was similar between treated and untreated groups (20/32 vs. 20/25, P = 0.13), and no untreated eyes developed complications requiring surgery. CONCLUSION: Not all patients with pediatric PP require treatment. Select mild cases may be safely observed without developing sequelae of chronic inflammation. Proper identification of these patients can reduce side effects and medication burden.
引用
- Xia JL, Shunyakova J, Hwang KM, et al. COMPARISON OF PEDIATRIC PATIENTS WITH PARS PLANITIS WHO UNDERWENT TREATMENT VERSUS OBSERVATION AT A TERTIARY REFERRAL EYE CENTER. Retina. 2026. PMID: 41570308. doi:10.1097/IAE.0000000000004787
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。